Multimodal strategy to identify novel diagnostic and therapeutic targets in lung and pancreatic cancer

确定肺癌和胰腺癌新诊断和治疗靶点的多模式策略

• 批准号: 333769
• 负责人: Tsao Ming-Sound
• 金额: $ 272.35万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2015
• 资助国家: 加拿大
• 起止时间: 2015-09-01 至 2022-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=333769&lang=en
• 关键词: Antibody; Bioinformatics; Cell Line; Microarray; Molecular Imaging; Molecular Pathology; Next Generation Sequencing; Patient Primary Tumor; Primary Xenograft; Shrna Screening

My research program focuses on lung and pancreatic cancer, the first and fourth most common cause of cancer deaths among Canadians. These two cancers account for 16% of new cancer cases in Canada in 2015, but disproportionately account for 33% of all canc

我的研究项目集中在肺癌和胰腺癌，加拿大人癌症死亡的第一和第四大常见原因。这两种癌症占2015年加拿大新发癌症病例的16%，但不成比例地占所有癌症病例的33%。